Thursday, December 3, 2020
Home Latest Pharma-News Cardiff University’s scientist awarded the funding of £373k to...

Cardiff University’s scientist awarded the funding of £373k to diagnose pancreatic cancer at an earlier stage

Nov 18, 2019: Dr Catherine Hogan at Cardiff University’s European Cancer Stem Cell Research Institute has been awarded the funding of £373k  by Cancer Research UK’s Early Detection Committee to understand new ways to diagnose pancreatic cancer at an earlier stage.

Her research showed that cells with the mutated KRAS gene (holds 90% of pancreatic cancer) are often eliminated due to protective mechanisms that keep the tissue healthy.

- Advertisement -

Nowadays many people survive with cancer and this doubled in the last 40 years in UK so funding awarded will helps a lot in investigating whether having more mutations in KRAS mutated cells enables them to avoid the protective mechanisms in the pancreas and initiate cancer development. https://www.cancerresearchuk.org/about-us/cancer-news/press-release/2019-11-06-cardiff-scientist-awarded-ps373k-to-find-new-ways-to-diagnose-pancreatic-cancer-earlier?_ga=2.170261608.979509868.1574138627-821077033.1573061409

LEAVE A REPLY

Please enter your comment!
Please enter your name here

seventeen − five =

Most Popular

FDA approves Xolair® (omalizumab) for adults with nasal polyps

December 01, 2020: "Roche announced that the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental Biologics License Application (sBLA)...

UK authorises Pfizer/BioNTech COVID-19 vaccine

December 02, 2020: "A Department of Health and Social Care spokesperson said: The government has accepted the recommendation from...

WHO Releases COVID-19 App for Trusted and Timely Updates

 December 01, 2020: The WHO has published a new mobile app to centralize the most trusted updates about COVID-19, and to guide...